잠시만 기다려 주세요. 로딩중입니다.

호르몬 대체요법시 Dydrogesterone이 지질대사 및 골대사에 미치는 영향

The Effects of Conjugated Equine Estrogens Plus Dydrogesterone on Lipid and Bone Metabolism in Postmenopausal Women

대한산부인과학회지 1997년 40권 5호 p.1037 ~ 1043
조수용
이재관/허준용/서호석/박용균/주갑순/임인수/이갑노

Abstract


The addition of a monthly course of progesterone decreases the incidence of endometrial hyperplasia and endometrial carcinoma. The progesterones used in hormonal replacement therapy (HRT) differ markedly in their progesteronic, androgenic and
even
estrogenic activities, These characteristics may influence both symptomatic and metabolic side effects.
The purpose of this study was to examine effect of bone and lipid metabolism in postmenopausal women treated with conjugated equine estrogens plus dydrogesterone.
A total 131 postmenopausal women(surgical menopause=95, natural menopause=36) and not-treated postmenopausal women(control=22) were invited to participate in this study. Patients were divided into groups which had received conjugated equine
estrogen(CEE) 0.625mg/day 21-day-cycle each month(n=20), CEE 0.625mg/day plus Dydrogesterone 10mg/day 10-day-cycle each month(n=111), and no treatment control group(n=20).
Serum lipid & lipoprotein(Triglyceride, Total cholesterol, High density lipoprotein, Low density lipoprotein) and serum osteocalcin, urinary Deoxypyridinoline were examined in all patients.
There were no significant differences in bone & lipid metabolism between CEE and CEE plus Dydrogesterone groups.
In conclusion, Dydrogesterone may be used safely in postmenopausal women without metabolic side effect.

키워드

원문 및 링크아웃 정보
  
등재저널 정보
KCI
KoreaMed
KAMS